Primary biliary cirrhosis and mitochondrial autoantigens—insights from molecular biology

Hepatology

Volumn 8, Issue 1, 1988, Pages 147-151

  Gershwin, M Eric ^a,b   Coppel, Ross L ^a,b   Mackay, Ian R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MITOCHONDRION ANTIBODY;

HUMAN; MOLECULAR BIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW;

ANIMAL; AUTOANTIGENS; AUTOIMMUNE DISEASES; HUMAN; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIA, LIVER;

EID: 0023876502     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840080128     Document Type: Article

References (76)

1. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis
2. In situ characterization of the cell‐surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis
3. Primary biliary cirrhosis
4. Reactivity of anti‐mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens
5. Antimitochondrial antibodies in primary biliary cirrhosis
6. Primary biliary cirrhosis: a model autoimmune disease
7. Complement activation in primary biliary cirrhosis: an in vitro model
8. Serum Fc‐receptor‐like molecules in primary biliary cirrhosis: a possible immunoregulatory mechanism
9. Alterations of T cell subsets in primary biliary cirrhosis
10. Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis
11. Lymphocyte subsets in primary biliary cirrhosis
12. Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis
13. Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identity with the 72,000 dalton autoantigen in primary biliary cirrhosis
14. Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen
15. Multiorgan granulomas and mitochondrial antibodies
16. Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis, and alcoholic liver disease
17. ATPase‐associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis
18. Olsson. Anti‐acetylcholine receptor antibodies in primary biliary cirrhosis
19. Lymphocytotoxic antibodies in primary biliary cirrhosis
20. Primary biliary cirrhosis and chronic active hepatitis: an examination of clinical, biochemical, and histopathological features in differential diagnosis
21. Is primary biliary cirrhosis a different disease in the elderly?
22. Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women?
23. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis
24. Are antimitochondrial antibodies of prognostic value in primary biliary cirrhosis?
25. Trial of penicillamine in advanced primary biliary cirrhosis
26. Treatment of primary biliary cirrhosis
27. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
28. Recurrence of primary biliary cirrhosis after liver transplantation
29. Primary biliary cirrhosis and liver transplantation
30. Primary biliary cirrhosis sharing a high titer of autoantibody
31. Serological tests in diagnosis of primary biliary cirrhosis
32. Is mitochondrial antibody diagnostic of primary biliary cirrhosis?
33. Heterogeneity of anti‐mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome
34. Serology of primary biliary cirrhosis
35. A simple enzyme‐linked immunosorbent assay for detection of anti‐mitochondrial antibodies
36. Detection of mitochondrial antibodies directed against the primary biliary cirrhosis (M2) antigen by an enzyme‐linked immunosorbent assay (ELISA)
37. An enzyme‐linked immunosorbent assay (ELISA) for detecting antimitochondrial antibody
38. Specificities and characteristics of mitochondrial protein antigens assessed by enzyme‐linked immunosorbent assay for anti‐mitochondrial antibodies. Relationship to immunofluorescent and precipitating antibodies
39. Precipitating anti‐mitochondrial antibodies in Japanese patients with primary biliary cirrhosis
40. Use of ATPase‐associated antigen (M2) for detection of antimitochondrial antibodies in primary biliary cirrhosis by fluorometric immunoassay
41. Primary biliary cirrhosis. Further biochemical and immunological characterization of mitochondrial antigens
42. The PBC specific antigen
43. Multiplicity of mitochondrial inner membrane antigens from beef heart reacting with antimitochondrial antibodies in sera of patients with primary biliary cirrhosis
44. Autoepitopes and autoimmune diseases
45. Serological classifications of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies
46. Characterization and clinical relevance of a new complement‐fixing antibody‐anti‐M8‐in patients with primary biliary cirrhosis
47. Evaluation of rheumatic disorders in patients with primary biliary cirrhosis
48. Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study
49. The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis
50. Inhibition of the adenine nucleotide translocator by organ specific autoantibodies in primary biliary cirrhosis
51. Sequence and organization of the human mitochondrial genome
52. How proteins find mitochondria and intramitochondrial compartments
53. Complete sequence of bovine mitochondrial DNA. Conserved features of the mammalian mitochondrial genome
54. Polymorphisms of mitochondrially encoded proteins
55. Aberrant expression of HLA‐DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis
56. Immunohistochemical characterization of inflammatory infiltrates in primary biliary cirrhosis
57. Immunohistochemical characterization of inflammatory infiltrates at the site of bile duct injury in primary biliary cirrhosis
58. The in vitro production of antibodies to mitochondrial antigens by peripheral blood mononuclear cells from patients with primary biliary cirrhosis
59. Preliminary communications. Cell‐mediated immune response in primary biliary cirrhosis to a protein fraction from human bile
60. Immunocytochemical localization of mitochondrial proteins in the rat hepatocyte
61. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases
62. In vitro anti‐mitochondrial antibody synthesis in patients with primary biliary cirrhosis
63. Ductular damage in liver transplant rejection. Its similarity to that of primary biliary cirrhosis and graft versus host disease
64. Relationship between primary biliary cirrhosis and chronic graft versus host disease: investigation of histocompatibility (HLA) antigenic determinants in biliary tract antigens
65. Species specificity and localization of encephalogenic sites in myelin basic protein
66. 1‐ATPase complex
67. Detection of mitochondria in bile canaliculi in early stage primary biliary cirrhosis cases
68. Localization of immunoglobulin on the liver cell surface in primary biliary cirrhosis
69. Immune complexes in primary biliary cirrhosis contain mitochondrial antigens
70. Circulating immune complexes and the pathogenesis of primary biliary cirrhosis
71. Detection of an antigen to primary biliary cirrhosis in wild type and petite mutant saccharomyces cerevisiae
72. Is the primary biliary cirrhosis‐specific antigen a primitive marker for all H‐ATPase?
73. T cell antigenic sites tend to be amphipathic structures
74. Construction of a synthetic immunogen using a new T helper epitope on the malaria circum‐sporozoite protein
75. Human T cell clones recognize a major M. leprae protein antigen expressed in E. coli